Close

Cellectar Biosciences (CLRB) Updates on Two Cohorts of CLR 131 Phase 1; Says Median Survival Continues Improving

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. BA
7. KMB
8. MSFT
9. FI
10. SPY


Go back to Cellectar Biosciences (CLRB) Updates on Two Cohorts of CLR 131 Phase 1; Says Median Survival Continues Improving
Cellectar Biosciences, Inc. (NASDAQ: CLRB) Delayed: 3.08 -0.03 (0.96%)
Previous Close $3.11    52 Week High $6.03 
Open $3.09    52 Week Low $0.41 
Day High $3.18    P/E N/A 
Day Low $3.00    EPS $0.00 
Volume 725,352       

(NASDAQ: CLRBW) Delayed: 0.13 --0 (-0%)
Previous Close $0.13    52 Week High $1.40 
Open $0.88    52 Week Low $0.11 
Day High $0.13    P/E N/A 
Day Low $0.13    EPS $0.00 
Volume 214,095       

(NASDAQ: CLRBZ) Delayed: 0.12 --0 (-0%)
Previous Close $0.12    52 Week High $1.88 
Open $58.27    52 Week Low $0.25 
Day High $0.12    P/E N/A 
Day Low $0.12    EPS $0.00 
Volume 6,852